Diurnal variation in serum remnant-like lipoproteins, platelet aggregation and fibrinolysis in healthy volunteers

Haemostasis

Volumn 27, Issue 6, 1998, Pages 305-314

  Rydzewski, A ^a,c,d   Urano, T ^a   Nagai, N ^a   Takada, Y ^a   Katoh Oishi, Y ^b   Taminato, T ^b   Yoshimi, T ^b   Takada, A ^a  

^a 2nd Department of Physiology

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^d Klinika Nefrologii AM   (Poland)

Author keywords

Circadian rhythm; Fibrinolysis; Platelet aggregation; Postprandial state; Remnant like lipoproteins; Serum lipids

Indexed keywords

CHOLESTEROL; CORTICOTROPIN; DEXAMETHASONE; HYDROCORTISONE; LIPOPROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; TRIACYLGLYCEROL;

ADULT; AREA UNDER THE CURVE; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; EUGLOBULIN LYSIS TEST; FIBRINOLYSIS; HUMAN; HUMAN EXPERIMENT; LIPID DIET; LIPOPROTEIN BLOOD LEVEL; MALE; NORMAL HUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION;

ADOLESCENT; ADRENOCORTICOTROPIC HORMONE; ADULT; APOLIPOPROTEINS; AREA UNDER CURVE; CHOLESTEROL; CIRCADIAN RHYTHM; DIETARY FATS; FIBRINOLYSIS; HUMANS; HYDROCORTISONE; JAPAN; LIPOPROTEINS; MALE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLATELET AGGREGATION; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TRIGLYCERIDES;

EID: 3543053385     PISSN: 03010147     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Havel R: Postprandial hyperlipidemia and remnant lipoproteins. Curr Opin Lipidol 1994;5:102-109.
2. Bladbjerg EM, Tholstrup T, Marckmann P, Sandström B, Jespersen J: Dietary changes in fasting levels of factor VII coagulant activity (F VII:C) are accompanied by changes in factor VII protein and other vitamin K-dependent proteins. Thromb Haemost 1995;73:239-242.
3. Kozima Y, Urano T, Serizawa K, Takada Y, Takada A: Impaired fibrinolytic activity induced by ingestion of butter: effect of increased plasma lipids on the fibrinolytic activity. Thromb Res 1993;70:191-202.
4. Zilversmit DB: Atherogenesis: A postprandial phenomenon. Circulation 1979;60:473-485.
5. Karpe F, Steiner G, Uffelman K, Olivecrona T, Hamsten A: Post-prandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis 1994;106:83-97.
6. Weintraub MS, Grosskopf I, Rassin T, Miller H, Charach G, Rotmensch HH, Rubinstein A, Iaina A: Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: Case control study over three years. Br Med J 1996;312:935-939.
7. Nakajima K, Saito T, Tamura A, Suzuki M, Nakano T, Adachi M, Tanaka A, Tada N, Nakamura H, Campos E, Havel RJ: Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels. Clin Chim Acta 1993; 223:53-71.
8. Takada A, Takada Y, Sakata K: Remnant-like particle cholesterol is a major risk factor for myocardial infarction in vasospastic angina without significant coronary artery narrowing (abstract). Thromb Haemost 1997 (suppl):519.
9. Rydzewski A, Sakata K, Urano T, Takada Y, Takada A: Remnant-like particles (RLP's) are increased in coronary artery disease (CAHD) (abstract). Thromb Haemost 1997 (suppl):326.
10. Tofler GH, Brezinski D, Schafer AI, Czeisler CA, Rutherford JD, Willich SN, Gleason RE, Williams GH, Muller JE: Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med 1987;316:1514-1518.
11. Cardinal DC, Flower RJ: The electronic aggregometer: A novel device for assessing platelet behavior in blood. J Pharmacol Methods 1980; 3:135-158.
12. Born GVR: Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962;194: 927-929.
13. Takada Y, Takada A: Measurement of the concentration of free plasminogen activator inhibitor (PAI-1) and its complex with tissue plasminogen activator. Thromb Res 1988;15-22.
14. Urano T, Sakakibara K, Rydzewski A, Urano S, Takada Y, Takada A: Relationship between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1. Thromb Haemost 1990;63:82-86.
15. Urano T, Sumiyoshi K, Pietraszek M, Takada Y, Takada A: PAI-1 plays an important role in the expression of t-PA activity in the euglobulin clot lysis by controlling the concentration of free t-PA. Thromb Haemost 1991;66:474-478.
16. Bridges AB, McLaren M, Scott NA, Pringle TH, McNeill GP, Belch JJ: Circadian variation of tissue plasminogen activator and its inhibitor, von Willebrand factor antigen, and prostacyclin stimulating factor in men with ischaemic heart disease. Br Heart J 1993;69:121-124.
17. Huber K, Rose D, Resch I, Schuster E, Glogar DH, Kaindl F, Binder BR: Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction. Thromb Haemost 1988;60:372-376.
18. Manfredini R, Gallerani M, Portaluppi F, Salmi R, Chierici F, Tassi A, Rizzioli E, Notarstefano P, Risichella IS, Mirizio AM, Fersini C: Chronobiologic aspects of ischemic coronary artery disease. Jpn Heart J 1996;37:829-836.
19. Sakata K, Hoshino T, Yoshida H, Ono N, Ohtani S, Yokoyama S, Mori N, Kaburagi T, Kurata C, Urano T: Circadian fluctuations of tissue plasminogen activator antigen and plasminogen activator inhibitor-1 antigens in vasospastic angina. Am Heart J 1992;124:854-860.
20. Kurnik PB: Practical implications of circadian variations in thrombolytic and antithrombotic activities. Cardiol Clin 1996;14:251-262.
21. Kurnik PB: Circadian variation in the efficacy of tissue-type plasminogen activator [see comments]. Circulation 1995;91:1341-1346.
22. Andreotti F, Kluft C: Circadian variation of fibrinolytic activity in blood. Chronobiol Int 1991;8:336-351.
23. Andrews NP, Gralnick HR, Merry-man P, Vail M, Quyyumi AA: Mechanisms underlying the morning increase in platelet aggregation: A flow cytometry study. J Am Coll Cardiol 1996;28:1789-1795.
24. Rosenfeld BA, Faraday N, Campbell D, Sakima N, Bell W: The effects of bedrest on circadian changes in hemostasis. Thromb Haemost 1994;72:281-284.
25. Angleton P, Chandler WL, Schmer G: Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1). Circulation 1989; 79:101-106.
26. Kluft C, Jie A, Rijken DC, Verheijen JH: Daytime fluctuations in blood of tissue-type plasminogen activator (t-PA) and its fast-acting inhibitor (PAI-1). Thromb Haemost 1988;59:329-332.
27. Takada A, Takada Y, Urano T, Sakakibara K, Rydzewski A: Fluctuations of euglobulin lysis time, tissue plasminogen activator, and free and total plasminogen activator inhibitor levels in plasma in daytime. Thromb Res 1990;57:13-20.
28. Chandler WL, Mornin D, Whitten RO, Angleton P, Farin FM, Fritsche TR, Veith RC, Stratton JR: Insulin, cortisol and catecholamines do not regulate circadian variations in fibrinolytic activity. Thromb Res 1990;58:1-12.
29. Urano T, Sumiyoshi K, Nakamura M, Mori T, Takada Y, Takada A: Fluctuation of tPA and PAI-1 antigen levels in plasma: Difference of their fluctuation patterns between male and female. Thromb Res 1990; 60:133-139.
30. Bridges AB, McLaren M, Saniabadi A, Fisher TC, Belch JJ: Circadian variation of endothelial cell function, red blood cell deformability and dehydrothromboxane B2 in healthy volunteers. Blood Coagul Fibrinolysis 1991;2:447-452.
31. Grimaudo V, Hauert J, Bachmann F, Kruithof EK: Diurnal variation of the fibrinolytic system. Thromb Haemost 1988;59:495-499.
32. Johansen LG, Gram J, Kluft C, Jespersen J: Circadian variation of fibrinolytic activity among Eskimos in Greenland. Arctic Med Res 1989; 48:204-207.
33. Winther K, Hillegass W, Tofler GH, Jimenez A, Brezinsky DA, Schafer AI, Loscalzo J, Williams GH, Muller JE: Effects on platelet aggregation and fibrinolytic activity during upright posture and exercise in healthy men. Am J Cardiol 1992;70: 1051-1055.
34. Kooistra T, Bosma PJ, Jespersen J, Kluft C: Studies on the mechanism of action of oral contraceptives with regard to fibrinolytic variables. Am J Obstet Gynecol 1990;163:404-413.
35. Iso H, Folsom AR, Koike KA, Sato S, Wu KK, Shimamoto T, Iida M, Komachi Y: Antigens of tissue plasminogen activator and plasminogen inhibitor 1: Correlates in nonsmoking Japanese and Caucasian men and women. Thromb Haemost 1993;70:475-480.
36. Marckmann P, Sandström B, Jespersen J: Dietary effects on circadian fluctuation in human blood coagulation factor VII and fibrinolysis. Atherosclerosis 1993;101:225-234.
37. Marckmann P, Sandström B, Jespersen J: Favorable long-term effect of a low-fat/high-fiber diet on human blood coagulation and fibrinolysis. Arterioscler Thromb 1993;13: 505-511.
38. Lopez-Segura F, Velasco F, Lopez-Miranda J, Castro P, Lopez-Pedrera R, Blanco A, Jimenez-Pereperez J, Torres A, Trujillo J, Ordovas JM, Perez-Jimenez F: Monounsaturated fatty acid-enriched diet decreases plasma plasminogen activator inhibitor type 1. Arterioscler Thromb Vasc Biol 1996;16:82-88.
39. Jafri SM, VanRollins M, Ozawa T, Mammen EF, Gpldberg AD, Goldstein S: Circadian variation in platelet function in healthy volunteers. Am J Cardiol 1992;69:951-954.
40. Malyszko J, Urano T, Knöfler R, Ihara H, Takada Y, Takada A: Relationships between serum lipids, serotonin, platelet aggregation and some fibrinolytic parameters in humans. Life Sci 1994;55:1619-1623.
41. Fujimura A, Ohashi K, Ebihara A: Daily variations in platelet aggregation and adhesion in healthy subjects. Life Sci 1992;50:1043-1047.
42. Johnston RV, Giner JV, Lowe GDO, Forbes CD, Prentice CRM: Prevention of lipid induced platelet aggregation by aspirin. Thromb Res 1982;27:235-239.
43. Jakubowski JA, Ardlie NG, Chesterman CN, McGready JF, Morgan FJ: Acute postprandial lipaemia does not influence the in vivo activity of human platelets. Thromb Res 1985; 39:725-732.
44. Knöfler R, Nakano T, Nakajima K, Takada Y, Takada A: Remnant-like lipoproteins stimulate whole blood platelet aggregation in vitro. Thromb Res 1995;78:161-171.
45. Saniabadi A, Suzuki Y, Kaku S, Umemura K, Nakashima M: Platelet aggregation induced by human plasma remnant like lipoprotein particles derived from very low density lipoproteins and chylomicrons (abstract). Thromb Haemost 1997 (suppl):257.
46. Orth M, Luley C, Wieland H: Effects of VLDL, chylomicrons, and chylomicron remnants on platelet aggregability. Thromb Res 1995;79: 297-305.
47. Joist JH, Baker RK, Schonfeld G: Increased in vivo and in vitro platelet function in type II and IV hyperlipoproteinemia. Thromb Res 1974; 15:95-108.
48. Larsson P, Hjemdahl P, Olsson G, Angelin B, Hornstra G: Platelet aggregability in humans: Contrasting in vivo and in vitro findings during sympatho-adrenal activation and relation to serum lipids. Eur J Clin Invest 1990;20:398-405.
49. Hassall DG, Forrest LA, Bruckdorfer KR, Marenah CB, Turner P, Corlese C, Miller NE, Lewis B: Influence of plasma lipoproteins on platelet aggregation in a normal male population. Arteriosclerosis 1983;3:332-338